Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Studies on the transmission of human (Hu) prions to transgenic (Tg) mice suggested that another molecule provisionally designated protein X participates in the formation of nascent scrapie isoform of prion protein (PrP Sc ). We report the identification of the site at which protein X binds to the cellular isoform of PrP (PrP C ) using scrapie-infected mouse (Mo) neuroblastoma cells transfected with chimeric Hu/MoPrP genes even though protein X has not yet been isolated. Substitution of a Hu residue at position 214 or 218 prevented PrP Sc formation. The side chains of these residues protrude from the same surface of the C-terminal α-helix and form a discontinuous epitope with residues 167 and 171 in an adjacent loop. Substitution of a basic residue at positions 167, 171, or 218 also prevented PrP Sc formation: at a mechanistic level, these mutant PrPs appear to act as “dominant negatives” by binding protein X and rendering it unavailable for prion propagation. Our findings seem to explain the protective effects of basic polymorphic residues in PrP of humans and sheep and suggest therapeutic and prophylactic approaches to prion diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mice devoid of PrP are resistant to scrapie
Büeler, H., Aguzzi, A., Sailer, A., Greiner, R.-A., Autenried, P., Aguet, M., & Weissmann, C. (1993) · Cell · doi:10.1016/0092-8674(93)90360-3 · Cited by 2,100
Molecular Biology of Prion Diseases
Prusiner, S. B. (1991) · Science · doi:10.1126/science.1675487 · Cited by 1,988
Self-citationNMR structure of the mouse prion protein domain PrP(121–231)
Riek, R., Hornemann, S., Wider, G., Billeter, M., Glockshuber, R., & Wüthrich, K. (1996) · Nature · doi:10.1038/382180a0 · Cited by 1,257
Prusiner, S. B., Scott, M., Foster, D., Pan, K.-M., Groth, D., Mirenda, C., Torchia, M., Yang, S.-L., Serban, D., Carlson, G. A., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90134-z · Cited by 871
Self-citationTelling, G. C., Parchi, P., DeArmond, S. J., Cortelli, P., Montagna, P., Gabizon, R., Mastrianni, J., Lugaresi, E., Gambetti, P., & Prusiner, S. B. (1996) · Science · doi:10.1126/science.274.5295.2079 · Cited by 865
Self-citationTelling, G. C., Scott, M., Mastrianni, J., Gabizon, R., Torchia, M., Cohen, F. E., DeArmond, S. J., & Prusiner, S. B. (1995) · Cell · doi:10.1016/0092-8674(95)90236-8 · Cited by 857
Self-citationLinkage of a prion protein missense variant to Gerstmann–Sträussler syndrome
Hsiao, K., Baker, H. F., Crow, T. J., Poulter, M., Owen, F., Terwilliger, J. D., Westaway, D., Ott, J., & Prusiner, S. B. (1989) · Nature · doi:10.1038/338342a0 · Cited by 849
Self-citationMouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins
Kascsak, R. J., Rubenstein, R., Merz, P. A., Tonna-DeMasi, M., Fersko, R., Carp, R. I., Wisniewski, H. M., & Diringer, H. (1987) · Journal of Virology · doi:10.1128/jvi.61.12.3688-3693.1987 · Cited by 766
Spontaneous Neurodegeneration in Transgenic Mice with Mutant Prion Protein
Hsiao, K. K., Scott, M., Foster, D., Groth, D. F., DeArmond, S. J., & Prusiner, S. B. (1990) · Science · doi:10.1126/science.1980379 · Cited by 530
Self-citationMASTERS, C. L., GAJDUSEK, D. C., & GIBBS, C. J. (1981) · Brain · doi:10.1093/brain/104.3.559 · Cited by 527
Cited by
Prusiner, S. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13363 · Cited by 5,373
Self-citationGaggelli, E., Kozlowski, H., Valensin, D., & Valensin, G. (2006) · Chemical Reviews · doi:10.1021/cr040410w · Cited by 1,729
Toxic Proteins in Neurodegenerative Disease
Taylor, J. P., Hardy, J., & Fischbeck, K. H. (2002) · Science · doi:10.1126/science.1067122 · Cited by 1,251
Eight prion strains have PrPSc molecules with different conformations
Safar, J., Wille, H., Itri, V., Groth, D., Serban, H., Torchia, M., Cohen, F. E., & Prusiner, S. B. (1998) · Nature Medicine · doi:10.1038/2654 · Cited by 1,245
Self-citationNMR solution structure of the human prion protein
Zahn, R., Liu, A., Lührs, T., Riek, R., von Schroetter, C., López García, F., Billeter, M., Calzolai, L., Wider, G., & Wüthrich, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.1.145 · Cited by 1,098
Prion Diseases and the BSE Crisis
Prusiner, S. B. (1997) · Science · doi:10.1126/science.278.5336.245 · Cited by 954
Self-citationPrusiner, S. B., Scott, M. R., DeArmond, S. J., & Cohen, F. E. (1998) · Cell · doi:10.1016/s0092-8674(00)81163-0 · Cited by 923
Self-citationNeurodegenerative Diseases and Prions
Prusiner, S. B. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105173442006 · Cited by 772
Self-citationDonne, D. G., Viles, J. H., Groth, D., Mehlhorn, I., James, T. L., Cohen, F. E., Prusiner, S. B., Wright, P. E., & Dyson, H. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13452 · Cited by 674
Self-citationViles, J. H., Cohen, F. E., Prusiner, S. B., Goodin, D. B., Wright, P. E., & Dyson, H. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2042 · Cited by 552
Self-citationPATHOLOGIC CONFORMATIONS OF PRION PROTEINS
Cohen, F. E., & Prusiner, S. B. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.793 · Cited by 533
Self-citationMoore, R. C., Lee, I. Y., Silverman, G. L., Harrison, P. M., Strome, R., Heinrich, C., Karunaratne, A., Pasternak, S. H., Chishti, M. A., Liang, Y., et al. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3108 · Cited by 530
Self-citationAntibodies inhibit prion propagation and clear cell cultures of prion infectivity
Peretz, D., Williamson, R. A., Kaneko, K., Vergara, J., Leclerc, E., Schmitt-Ulms, G., Mehlhorn, I. R., Legname, G., Wormald, M. R., Rudd, P. M., et al. (2001) · Nature · doi:10.1038/35089090 · Cited by 525
Self-citationJames, T. L., Liu, H., Ulyanov, N. B., Farr-Jones, S., Zhang, H., Donne, D. G., Kaneko, K., Groth, D., Mehlhorn, I., Prusiner, S. B., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10086 · Cited by 452
Self-citationPrusiner, S. B. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00171.x · Cited by 392
Self-citationBinding of neural cell adhesion molecules (N-CAMs) to the cellular prion protein
Schmitt-Ulms, G., Legname, G., Baldwin, M. A., Ball, H. L., Bradon, N., Bosque, P. J., Crossin, K. L., Edelman, G. M., DeArmond, S. J., Cohen, F. E., et al. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.5183 · Cited by 387
Self-citationNMR structure of the bovine prion protein
López García, F., Zahn, R., Riek, R., & Wüthrich, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.15.8334 · Cited by 385
DePace, A. H., Santoso, A., Hillner, P., & Weissman, J. S. (1998) · Cell · doi:10.1016/s0092-8674(00)81467-1 · Cited by 364
Conversion of α-lactalbumin to a protein inducing apoptosis.
Svensson, M., Håkansson, A., Mossberg, A.-K., Linse, S., & Svanborg, C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.8.4221 · Cited by 355
Weissmann, C. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro1025 · Cited by 346
Transmissible spongiform encephalopathies
Collins, S. J., Lawson, V. A., & Masters, C. L. (2004) · The Lancet · doi:10.1016/s0140-6736(03)15171-9 · Cited by 339
Implications of peptide assemblies in amyloid diseases
Ke, P. C., Sani, M.-A., Ding, F., Kakinen, A., Javed, I., Separovic, F., Davis, T. P., & Mezzenga, R. (2017) · Chemical Society Reviews · doi:10.1039/c7cs00372b · Cited by 338
Peretz, D., Williamson, R. A., Matsunaga, Y., Serban, H., Pinilla, C., Bastidas, R. B., Rozenshteyn, R., James, T. L., Houghten, R. A., Cohen, F. E., et al. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1328 · Cited by 336
Self-citationIdentification of interaction domains of the prion protein with its 37-kDa/67-kDa laminin receptor
Hundt, C. (2001) · The EMBO Journal · doi:10.1093/emboj/20.21.5876 · Cited by 291
A systems approach to prion disease
Hwang, D., Lee, I. Y., Yoo, H., Gehlenborg, N., Cho, J., Petritis, B., Baxter, D., Pitstick, R., Young, R., Spicer, D., et al. (2009) · Molecular Systems Biology · doi:10.1038/msb.2009.10 · Cited by 287
“Soto et al , 2005 ) and an unknown factor that binds to a C-terminal region of PrP may be limiting for cross-species transmission as a facilitator of conversion”
BackgroundConsequences of manganese replacement of copper for prion protein function and proteinase resistance
Brown, D. R. (2000) · The EMBO Journal · doi:10.1093/emboj/19.6.1180 · Cited by 269
Prion protein NMR structures of elk and of mouse/elk hybrids
Gossert, A. D., Bonjour, S., Lysek, D. A., Fiorito, F., & Wüthrich, K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409008102 · Cited by 268
A systematic review of prion therapeutics in experimental models
Trevitt, C. R. (2006) · Brain · doi:10.1093/brain/awl150 · Cited by 263
Lipid rafts: structure, function and role in HIV, Alzheimer's and prion diseases
Fantini, J., Garmy, N., Mahfoud, R., & Yahi, N. (2002) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399402005392 · Cited by 258
Identification of a Common Sphingolipid-binding Domain in Alzheimer, Prion, and HIV-1 Proteins
Mahfoud, R., Garmy, N., Maresca, M., Yahi, N., Puigserver, A., & Fantini, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111679200 · Cited by 232
Horiuchi, M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.12.3193 · Cited by 226
“Of particular interest is the lack of inhibition by the antibodies recognizing residues 90–104 and 106–115 (mAb 3F4) because residues in these regions have been shown to influence PrP-res formation (Muramoto et al., 1996; Kaneko et al., 1997a; Chabry et al., 1998; Hölscher et al., 1998).”
BackgroundSupattapone, S., Bosque, P., Muramoto, T., Wille, H., Aagaard, C., Peretz, D., Nguyen, H.-O. B., Heinrich, C., Torchia, M., Safar, J., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80596-6 · Cited by 206
Self-citationTwo different neurodegenerative diseases caused by proteins with similar structures
Mo, H., Moore, R. C., Cohen, F. E., Westaway, D., Prusiner, S. B., Wright, P. E., & Dyson, H. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051627998 · Cited by 169
Self-citationThe prion hypothesis: from biological anomaly to basic regulatory mechanism
Tuite, M. F., & Serio, T. R. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3007 · Cited by 146
Metadata
- Authors
- Kaneko, K., Zulianello, L., Scott, M., Cooper, C. M., Wallace, A. C., James, T. L., Cohen, F. E., & Prusiner, S. B.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1997-09-16
- Volume
- 94
- Issue
- 19
- Pages
- 10069-10074
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2018675827
- Cited by
- 515
- References
- 44
- FWCI
- 8.55
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.